Skip to Content
Merck
CN
All Photos(1)

Documents

Safety Information

542334

Sigma-Aldrich

IGEPAL® CO-630

average Mn 617

Synonym(s):

Polyoxyethylene (9) nonylphenylether, branched

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
(C2H4O)n · C15H24O · n=9-10
CAS Number:
MDL number:
UNSPSC Code:
12162002
NACRES:
NA.23

mol wt

average Mn 617

Quality Level

bp

250 °C (lit.)

density

1.056 g/mL at 25 °C (lit.)

HLB

13

Related Categories

General description

IGEPAL® CO-630 is an alkylphenol ethoxylate that is majorly used as an anionic surfactant. It belongs to the IGEPAL series of surfactants, which have hydrophobic chains. Its properties include low surface tension, low sensitivity, and biocompatibility

Application

Nonionic surfactant.

Legal Information

IGEPAL is a registered trademark of Solvay

Pictograms

Environment

Signal Word

Warning

Hazard Statements

Precautionary Statements

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

监管及禁止进口产品

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  3. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  4. What physical form is Product 542334, IGEPAL® CO-630?

    This product is a liquid.

  5. What is the concentration of Product 542334, IGEPAL® CO-630?

    Based on a reported density of 1.056 g/mL at 25 °C(lit.), and a reported average molecular weight of Mn ~617. The approximate molar concentration is 1.7 M.

  6. What is the cloud point of Product 542334, IGEPAL® CO-630?

    The cloud point of a 1% solution is 52°C-56°C.

  7. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  8. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

Preparation of highly concentrated stable dispersions of uniform silver nanoparticles
Sondi I, et al.
Journal of Colloid and Interface Science, 260(1), 75-81 (2003)
Wetting of TX-100 and Igepal CO-630 Surfactants on a PTFE Surface
Biswal NR and Paria S
Industrial & Engineering Chemistry Research, 50(10), 6138-6145 (2011)
Wettability of a PTFE surface by cationic-non-ionic surfactant mixtures in the presence of electrolytes
Chaudhuri RG, et al.
Soft Matter, 8(20), 5429-5433 (2012)
Viktorija Herceg et al.
Molecules (Basel, Switzerland), 25(18) (2020-09-24)
Cyclopeptidic chemotherapeutic prodrugs (cPCPs) are macromolecular protease-sensitive doxorubicin (DOX) prodrugs synthesized from a cyclodecapeptidic scaffold, termed Regioselectively Addressable Functionalized Template (RAFT). In order to increase the chemotherapeutic potential of DOX and limit its toxicity, we used a Cathepsin B (Cat
Mirko Trilling et al.
Journal of virology, 83(8), 3684-3695 (2009-02-13)
Vaccinia virus (VACV) replicates in mouse and human fibroblasts with comparable kinetics and efficiency, yielding similar titers of infectious progeny. Here we demonstrate that gamma interferon (IFN-gamma) but not IFN-alpha or IFN-beta pretreatment of mouse fibroblasts prior to VACV infection

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service